Deferred Tax Assets, Valuation Allowance of ATOSSA THERAPEUTICS, INC. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ATOSSA THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • ATOSSA THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $29,516,000, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $29,516,000 +$4,870,000 +20% 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q4 2023 $24,646,000 +$5,319,000 +28% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q4 2022 $19,327,000 +$4,390,000 +29% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $14,937,000 +$4,903,000 +49% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q4 2020 $10,034,000 +$2,985,912 +42% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $7,048,088 +$1,735,319 +33% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $5,312,769 +$2,223,463 +72% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q4 2017 $3,089,306 -$15,510,694 -83% 31 Dec 2017 10-K 28 Mar 2019 2018 FY
Q4 2016 $18,600,000 +$1,100,000 +6.3% 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q4 2015 $17,500,000 +$6,102,600 +54% 31 Dec 2015 10-K/A 21 Mar 2017 2016 FY
Q4 2014 $11,397,400 +$4,409,800 +63% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q4 2013 $6,987,600 31 Dec 2013 10-K 30 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.